SCHEMBL206266

SCHEMBL206266

FC(F)(F)c1cc(Nc2nccs2)ccc1OCCCC1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HPGD P15428 1/20 0.41
POLB P06746 1/20 0.41
EPHX2 P34913 1/20 0.38
PLA2G7 Q13093 1/20 0.37
USP2 O75604 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SCN1A P35498 2/20 0.37
SCN8A Q9UQD0 2/20 0.37
FABP4 P15090 1/20 0.36
FABP5 Q01469 1/20 0.36
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CCNA1 P78396 1/20 0.35
S1PR1 P21453 1/20 0.35
ULK1 O75385 1/20 0.35
ULK2 Q8IYT8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2697660 0.85 HPGD (0.39) HPGDNPSR1FABP4FABP5S1PR1
SCHEMBL206025 0.82 S1PR1 (0.51) ALDH1A1TDP1MEN1KMT2APOLB
SCHEMBL206523 0.81 S1PR1 (0.53) ALDH1A1TDP1MEN1KMT2APLA2G7
SCHEMBL207006 0.80 ALOX5 (0.45) ALDH1A1TDP1MEN1KMT2AHPGD
SCHEMBL208662 0.79 MEN1 (0.49) ALDH1A1TDP1MEN1KMT2ALMNA
SCHEMBL205364 0.78 MCHR1 (0.39) MEN1KMT2AHPGDNPSR1MAPT
SCHEMBL205730 0.77 MCHR1 (0.40) ALDH1A1MEN1KMT2AHPGDNPSR1
SCHEMBL205565 0.77 MCHR1 (0.42) ALDH1A1MEN1KMT2AULK1ULK2
SCHEMBL207103 0.77 CHRNA7 (0.39) MEN1KMT2AHPGDFABP4FABP5
SCHEMBL3130600 0.76 CHRNA7 (0.36) HPGDFABP4FABP5ULK1ULK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 ALDH1A1 109/4885TDP1 1045/4885MEN1 3862/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 ALDH1A1 109/4885TDP1 1045/4885MEN1 3862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.